Wouter Kortlandt

723 total citations
32 papers, 596 citations indexed

About

Wouter Kortlandt is a scholar working on Nephrology, Surgery and Epidemiology. According to data from OpenAlex, Wouter Kortlandt has authored 32 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 7 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Wouter Kortlandt's work include Lipoproteins and Cardiovascular Health (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Lipid metabolism and disorders (3 papers). Wouter Kortlandt is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Lipid metabolism and disorders (3 papers). Wouter Kortlandt collaborates with scholars based in Netherlands, Sweden and Germany. Wouter Kortlandt's co-authors include D.W. Erkelens, E. J. Dorhout Mees, Hans Jansen, M. Castro Cabezas, L A Kock, H. A. Koomans, T W de Bruin, Anton B. Geers, H.J.M. van Rijn and Bonno N. Bouma and has published in prestigious journals such as Analytical Biochemistry, American Journal of Epidemiology and Diabetologia.

In The Last Decade

Wouter Kortlandt

32 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wouter Kortlandt Netherlands 14 209 193 145 135 120 32 596
J.F. Moorhead United Kingdom 19 148 0.7× 257 1.3× 72 0.5× 139 1.0× 297 2.5× 46 937
Pin‐Ming Liu China 15 130 0.6× 113 0.6× 164 1.1× 111 0.8× 76 0.6× 50 563
Christopher C. Kaltenecker Austria 13 180 0.9× 227 1.2× 160 1.1× 99 0.7× 147 1.2× 21 643
Kemal Erbil Türkiye 12 58 0.3× 93 0.5× 187 1.3× 123 0.9× 128 1.1× 19 638
Jennifer A. Schaub United States 12 100 0.5× 100 0.5× 78 0.5× 107 0.8× 155 1.3× 25 537
Young Sook Hong South Korea 16 129 0.6× 60 0.3× 76 0.5× 215 1.6× 74 0.6× 76 792
M. Seigneur France 18 65 0.3× 174 0.9× 189 1.3× 108 0.8× 25 0.2× 31 891
M. C. Stone United Kingdom 10 199 1.0× 119 0.6× 126 0.9× 70 0.5× 29 0.2× 14 616
Hiroaki Ikezaki Japan 18 351 1.7× 263 1.4× 151 1.0× 111 0.8× 34 0.3× 56 882
Gaosi Xu China 16 172 0.8× 78 0.4× 116 0.8× 135 1.0× 303 2.5× 65 816

Countries citing papers authored by Wouter Kortlandt

Since Specialization
Citations

This map shows the geographic impact of Wouter Kortlandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter Kortlandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter Kortlandt more than expected).

Fields of papers citing papers by Wouter Kortlandt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter Kortlandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter Kortlandt. The network helps show where Wouter Kortlandt may publish in the future.

Co-authorship network of co-authors of Wouter Kortlandt

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter Kortlandt. A scholar is included among the top collaborators of Wouter Kortlandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter Kortlandt. Wouter Kortlandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vijzelaar, Raymon, et al.. (2016). Rapid Detection of the Three Celiac Disease Risk Genotypes HLA-DQ2.2, HLA-DQ2.5, and HLA-DQ8 by Multiplex Ligation-Dependent Probe Amplification. Genetic Testing and Molecular Biomarkers. 20(3). 158–161. 2 indexed citations
2.
Kortlandt, Wouter, et al.. (2012). Quality of intraoperatively salvaged unwashed blood in hip arthroplasty. Transfusion and Apheresis Science. 48(2). 207–211. 3 indexed citations
3.
4.
Hannen, Erik J. van, et al.. (2011). Rapid HLA-B27 screening with real-time TaqMan PCR: a clinical validation in the Dutch population. Clinical Chemistry and Laboratory Medicine (CCLM). 49(12). 1979–85. 8 indexed citations
5.
Veldhuis, Wouter B., Malou Janssen, Wouter Kortlandt, A.J. van Houte, & Marcel A. van de Ree. (2004). Coombs-negative severe haemolytic anaemia in an immunocompetent adult following cytomegalovirus infection. European Journal of Clinical Microbiology & Infectious Diseases. 23(11). 844–847. 9 indexed citations
6.
7.
Cabezas, M. Castro, T W de Bruin, Hans Jansen, et al.. (1993). Impaired chylomicron remnant clearance in familial combined hyperlipidemia.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(6). 804–814. 116 indexed citations
8.
Cabezas, M. Castro, Tjerk W.A. de Bruin, L A Kock, et al.. (1993). Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion. Metabolism. 42(4). 497–503. 64 indexed citations
9.
Kortlandt, Wouter, et al.. (1992). Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus. Diabetologia. 35(3). 202–207. 21 indexed citations
10.
Joles, J.A., et al.. (1991). Hyperlipoproteinemia in one-year-old analbuminemic rats. Atherosclerosis. 88(1). 35–47. 21 indexed citations
11.
Bruin, Tjerk W.A. de, Martine De Vos, Wouter Kortlandt, Bonno N. Bouma, & D.W. Erkelens. (1990). Proteolysis of human apolipoprotein B: effect on quantitative immunoturbidimetry. Clinica Chimica Acta. 193(3). 137–145. 13 indexed citations
12.
Zonderland, Maria L., W. Erich, D.W. Erkelens, et al.. (1990). Plasma lipids and apoproteins, body fat distribution and body fatness in early pubertal children.. PubMed. 14(12). 1039–46. 19 indexed citations
13.
Kortlandt, Wouter, et al.. (1989). A simple method for the measurement of total and glycated apolipoprotein B and its relevance to apolipoprotein-B metabolism in diabetes mellitus. Clinica Chimica Acta. 186(1). 109–117. 14 indexed citations
14.
Joles, J.A., et al.. (1989). Effect of hypoproteinemia on blood volume recovery after moderate hemorrhage in conscious splenectomized dogs. Journal of Surgical Research. 47(6). 515–519. 6 indexed citations
15.
Joles, Jaap A., et al.. (1989). Plasma proteins in growing analbuminaemic rats fed on a diet of low-protein content. British Journal Of Nutrition. 61(3). 485–494. 10 indexed citations
16.
Kortlandt, Wouter, et al.. (1986). Characterization of α-MSH-like immunoreactivity in human plasma. European Journal of Endocrinology. 113(2). 175–180. 3 indexed citations
17.
Koomans, H. A., Anton B. Geers, E. J. Dorhout Mees, & Wouter Kortlandt. (1986). Lowered Tissue-Fluid Oncotic Pressure Protects the Blood Volume in the Nephrotic Syndrome. ˜The œNephron journals/Nephron journals. 42(4). 317–322. 28 indexed citations
18.
Koomans, H. A., Anton B. Geers, Wouter Kortlandt, & E. J. Dorhout Mees. (1985). Albumin infused in nephrotics: where does it go?. PubMed. 28(4). 148–52. 7 indexed citations
19.
Koomans, Hendrik A., Wouter Kortlandt, Anton B. Geers, & E. J. Dorhout Mees. (1985). Lowered Protein Content of Tissue Fluid in Patients with the Nephrotic Syndrome: Observations during Disease and Recovery. ˜The œNephron journals/Nephron journals. 40(4). 391–395. 42 indexed citations
20.
Kortlandt, Wouter, et al.. (1985). Comparison of Three Different Assay Procedures for the Determination of HbA1 with Special Attention to the Influence of Pre-HbA1c, Temperature and Haemoglobin Concentration. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 22(3). 261–268. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.F. Moorhead Breakdown of academic impact, for papers by Pin‐Ming Liu Breakdown of academic impact, for papers by Christopher C. Kaltenecker Breakdown of academic impact, for papers by Kemal Erbil Breakdown of academic impact, for papers by Jennifer A. Schaub Breakdown of academic impact, for papers by Young Sook Hong Breakdown of academic impact, for papers by M. Seigneur Breakdown of academic impact, for papers by M. C. Stone Breakdown of academic impact, for papers by Hiroaki Ikezaki Breakdown of academic impact, for papers by Gaosi Xu
Rankless by CCL
2026